Revision history of "Realworld analysis of the Celgene International Drug Basic safety data source first discontinuation of lenalidomide within patients together with myelodysplastic syndromes because of nonserious hasty"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.